Nicola was Head Safety Evaluation & Risk Management Italy at GSK Vaccines, and Global Head, Clinical Trial Serious Adverse Event Management at Novartis. Nicola Groth joined Osivax in 2024.
Nicola Groth is currently
Create your alert
to follow the career of Nicola Groth.
Nicola Groth has a PhD in Medicine from University of Siena.
Do you need to know more about Nicola Groth? More results.
Report an error
Update the org chart details of Nicola Groth.
Here are a few tips for establishing great contacts.
Discover the organization charts of your favorite companies.
Spot the influential executives using our search tools.
Receive notifications when executive positions change.